InvestorsHub Logo
Followers 400
Posts 26012
Boards Moderated 0
Alias Born 02/12/2003

Re: None

Sunday, 04/17/2011 7:10:30 PM

Sunday, April 17, 2011 7:10:30 PM

Post# of 6405
Email from Mr. Salari concerning...

the difference of our and theirs...

Dear Dr. Salari,

I have an urgent question I would like ask you about to get the factual data regarding this issue. I appreciate you taking the time to personally address such issues from investors, as you have in the past.

I was doing a little research last night and stumbled on to a site that is selling cialis sublingual. Here is the link to the site selling it and many other sites are selling it too. It even explains how cialis sublingual works by going directly into the blood stream to reduce side effects and speed up delivery.

My question is: If Lily already has this approved in the UK, what is it exactly that GHLV has that is patented and using in their trial that differs from cialis sub-lingual?

Answer.....

There is no difference. Except the API (Active Pharmaceutical Ingredient) is different. Ours the API is “Sildenafil”, theirs the API is “Tadalafil”.

Follow up post...

GHLV is going after the Viagra market - the most popular, lucrative and preferred ED treatment.

Hope this helps,

Contributed by SLBrown...

VLF

I dont care if you're a Pumper or a Basher. Just act like an adult, and live by the decisions you have made. Im not your Momma.

Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.